MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PCVX has $3,002,717K in assets. $317,207K in debts. $173,959K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
790.94%
Quick Ratio
790.94%
Cash Ratio
84.55%
Debt to Asset Ratio
10.56%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities lon...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
173,959
Short-term investments
1,387,000
Prepaid expenses and other current assets
66,402
Total current assets
1,627,361
Property and equipment, net
257,370
Operating lease right-of-use assets
116,009
Long-term investments
881,664
Restricted cash
1,466
Other assets
118,847
Total noncurrent assets
1,375,356
Total assets
3,002,717
Accounts payable
70,904
Accrued compensation
23,000
Accrued contract manufacturing expenses
74,654
Accrued expenses
31,068
Operating lease liabilities current
6,124
Total current liabilities
205,750
Operating lease liabilities long-term
111,357
Other liabilities
100
Total liabilities
317,207
Common stock, 0.001 par value 500,000,000 shares authorized at december31, 2025 and december31, 2024 131,058,858 and 124,893,034 shares issued and outstanding at december31, 2025 and december31, 2024, respectively
134
Additional paid-in capital
4,838,736
Accumulated other comprehensive income (loss)
1,587
Accumulated deficit
-2,154,947
Total stockholders' equity
2,685,510
Total liabilities and stockholders' equity
3,002,717
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$1,387,000K Cash and cashequivalents$173,959K Prepaid expenses andother current assets$66,402K Long-term investments$881,664K Property and equipment,net$257,370K Other assets$118,847K Operating leaseright-of-use assets$116,009K Restricted cash$1,466K Total current assets$1,627,361K Total noncurrentassets$1,375,356K Total assets$3,002,717K Total liabilities andstockholders' equity$3,002,717K Total stockholders'equity$2,685,510K Total liabilities$317,207K Accumulated deficit-$2,154,947K Additional paid-in capital$4,838,736K Total currentliabilities$205,750K Operating leaseliabilities long-term$111,357K Other liabilities$100K Accumulated othercomprehensive income (loss)$1,587K Common stock, 0.001 parvalue 500,000,000...$134K Accrued contractmanufacturing expenses$74,654K Accounts payable$70,904K Accrued expenses$31,068K Accrued compensation$23,000K Operating leaseliabilities current$6,124K

Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. (PCVX)